Frederick Simonie, MD
Cardiology · Scottsdale, AZNPI 1932165958
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $54 of the $74 with a category attached, or 72.8%. Amgen accounts for 72.8% of it on its own, with 1 other manufacturer making up the rest.
Across 3 payments — averaging $24.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$54
- Bayer$20
What the payments were for
- Food & beverage$5473%
- Education$2027%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
Too few cardiology providers in Arizonato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 503 | $580,465 |
| Repatha SureclickEvolocumab | 213 | $219,419 |
| JardianceEmpagliflozin | 89 | $129,974 |
| EntrestoSacubitril/Valsartan | 74 | $112,818 |
| XareltoRivaroxaban | 88 | $111,526 |
| VascepaIcosapent Ethyl | 91 | $77,942 |
| Praluent PenAlirocumab | 69 | $62,962 |
| FarxigaDapagliflozin Propanediol | 42 | $44,945 |
| Ezetimibe | 825 | $25,747 |
| NexletolBempedoic Acid | 22 | $21,330 |
| Rosuvastatin Calcium | 966 | $13,287 |
| LivaloPitavastatin Calcium | 12 | $11,676 |
| Metoprolol Succinate | 558 | $10,435 |
| Icosapent Ethyl | 19 | $9,274 |
| Repatha SyringeEvolocumab | 12 | $8,817 |
Paid to pharmacies, not to this prescriber.
Other cardiology in Scottsdale
- Carolyn LarsenScottsdale$0
- Susan Wilansky MarkowitzScottsdale$0
- Abdul TajikScottsdale$0
- David SimperScottsdale$0
- John LynchScottsdale$0
- Habteab FesehaYuma$18K
- Tri NguyenPhoenix$12K
- Paul DuongPhoenix$11K
- Maher AwarYuma$5K
- Nitin PatelPrescott Valley$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.